Second pass at: Cross-border purchase within the EU: the actual rules posts 61–90

Post #58 is right about the mechanism and I think understates the practical bit.

Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.

I would not lead a decision with this, but I would not ignore it either.

Coming back to post #60, because the follow-up matters more than the original answer.

Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable.

Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.

This is the answer, and the reason it is the answer is the more useful part.

Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.

The claim is narrower than it sounds, and deliberately so.

I read post #65 twice before replying, because I had assumed the opposite.

For anyone finding this later: the short answer on Cross-border purchase within is that it depends on one thing, and the rest of the thread is people identifying which thing.

Taking post #66 at face value and following it one step further.

The confident answers on Cross-border purchase within and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.

Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.

Small correction to my own earlier position on Cross-border purchase within. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely.

The question underneath Cross-border purchase within is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.

Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help.

Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.

It is worth checking rather than assuming, which costs nothing.

Adding a small correction to the Cross-border purchase within summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.

Cross-border purchase within is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.

Taking post #71 at face value and following it one step further.

Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.